MPD: Phenotype measures mapped to VT:0005369, muscular system trait

An error occurred on this page.
These results could be incomplete or invalid. Staff have been notified.

Phenotype measures associated with ontology term
VT:0005369 'muscular system trait'

All measures in this list are mapped to the ontology descendants of VT:0005369. None are mapped to VT:0005369 directly.

VT:0003081 soleus morphology trait
VT:0003082 gastrocnemius morphology trait
VT:0003083 tibialis anterior morphology trait
VT:0003084 skeletal muscle fiber morphology trait
VT:0003398 skeletal muscle size trait
VT:0004142 muscle tone
VT:0004246 extensor digitorum longus morphology trait
VT:0010080 skeletal muscle physiology trait
VT:0010119 skeletal muscle cellular composition trait
VT:0010569 quadriceps morphology trait
VT:0010648 muscle glycogen amount
VT:1000429 muscle lactate amount
VT:1000712 skeletal muscle mass
VT:1000747 type I muscle fiber quantity
VT:1000748 type IIa muscle fiber quantity

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Auwerx1:221	Auwerx1	organ weights	high-fat diet	skeletal muscle weight [g] muscle_wt 111400 CD HFD	BXD w/par	57	m	29wks	N=4	2016

Auwerx1:233	Auwerx1	organ weights	high-fat diet	soleus muscle weight [g] soleus_wt 111412 CD HFD	BXD w/par	57	m	29wks	N=4	2016

Brockmann1:8	Brockmann1	muscle weights	(none)	muscle weight [mg] Mw 21308	QTL population		both	6wks	N=138	2009

Brockmann1:25	Brockmann1	muscle weights	(none)	muscle weight [mg] mw 21505	QTL population		both	6wks	N=201	2009

Churchill1:9	Churchill1	muscle weights	(none)	weight of isolated quadriceps muscle [g] quadricep_wt 17109	F1 8way	63	both	7-8wks	N=5	2004

Crabbe4:6	Crabbe4	grip strength	ethanol	grip strength test: peak force applied [g] grip 19106 baseline 30min after ethanol	inbred	21	both	7-12wks	N=6	2003

Crabbe4:8	Crabbe4	grip strength	ethanol	change in peak force applied (T0-T30) post-injection, grip strength test [g] gripEtOHeffect 19108	inbred	21	both	7-12wks	N=6	2003

Crabbe4:9	Crabbe4	grip strength	ethanol	percent change in average latency to fall post-injection, grip strength test [%] pct_gripchange 19109	inbred	21	both	7-12wks	N=6	2003

Donahue2:22	Donahue2	DXA	(none)	cross-sectional area of thigh muscle and bone, femoral mid-diaphysis [mm²] thigh_area 17222	inbred	10	both	16wks	N=10	2004

Donahue2:23	Donahue2	DXA	(none)	cross-sectional thigh muscle area (thigh area minus femur area), femoral mid-diaphysis [mm²] thigh_muscle_area 17223	inbred	10	both	16wks	N=10	2004

Donahue2:24	Donahue2	muscle weights	(none)	weight of isolated right quadriceps muscle [g] quadricep_wt 17224	inbred	10	both	16wks	N=10	2004

GMC02:11	GMC02	grip strength	(none)	forelimb grip strength [g] front_paws 55111 trial1 trial2 trial3	inbred w/CC8	8	both	8-10wks	N=17	2018

GMC02:14	GMC02	grip strength	(none)	forelimb grip strength, mean [g] front_paws_mean 55114	inbred w/CC8	8	both	8-10wks	N=17	2018

GMC02:15	GMC02	grip strength	(none)	forelimb grip strength (mean) normalized to body weight [ratio] front_paws_adj 55115	inbred w/CC8	8	both	8-10wks	N=17	2018

GMC02:21	GMC02	grip strength	(none)	forelimb and hindlimb grip strength [g] all_paws 55121 trial1 trial2 trial3	inbred w/CC8	8	both	8-10wks	N=17	2018

GMC02:24	GMC02	grip strength	(none)	forelimb and hindlimb grip strength, mean [g] all_paws_mean 55124	inbred w/CC8	8	both	8-10wks	N=17	2018

GMC02:25	GMC02	grip strength	(none)	forelimb and hindlimb grip strength (mean) normalized to body weight [ratio] all_paws_adj 55125	inbred w/CC8	8	both	8-10wks	N=17	2018

GMC03:20	GMC03	observation (SHIRPA)	(none)	gait (0=fluid, 1=abnormal) [score] gait 55244	inbred w/CC8	8	both	8-10wks	N=17	2018

JaxCC1:9096	JaxCC1	grip strength	(none)	forelimb grip strength [g] front_paws 89096 trial1 trial2 trial3	CC	18	both	7-9wks	N=7	2017

JaxCC1:9099	JaxCC1	grip strength	(none)	forelimb grip strength [g] front_paws_summ 89099 average average normalized to bw	CC	18	both	7-9wks	N=7	2017

JaxCC1:9106	JaxCC1	grip strength	(none)	forelimb and hindlimb grip strength [g] all_paws 89106 trial1 trial2 trial3	CC	18	both	7-9wks	N=7	2017

JaxCC1:9109	JaxCC1	grip strength	(none)	forelimb and hindlimb grip strength [g] all_paws_summ 89109 average average normalized to bw	CC	18	both	7-9wks	N=7	2017

JaxKOMP-EAP:35	JaxKOMP-EAP	grip strength	(none)	forelimb grip strength by trial [g] front_paws forelimb_strength 100561 trial1 trial2 trial3	KOMP	1725	both	8wks	N=8	2021

JaxKOMP-EAP:38	JaxKOMP-EAP	grip strength	(none)	forelimb and hindlimb grip strength by trial [g] all_paws forehind_limb_strength 100564 trial1 trial2 trial3	KOMP	1725	both	8wks	N=8	2021

JaxKOMP-EAP:42	JaxKOMP-EAP	grip strength	(none)	forelimb grip strength (mean of trials) [g] front_paws_mean forelimb_grip_mean 100571 average average normalized to bw	KOMP	1725	both	8wks	N=8	2021

JaxKOMP-EAP:44	JaxKOMP-EAP	grip strength	(none)	forelimb and hindlimb grip strength (mean of trials) [g] all_paws_mean fore_and_hind_limb_grip_mean 100572 average average normalized to bw	KOMP	1725	both	8wks	N=8	2021

JaxKOMP-LAP:131	JaxKOMP-LAP	grip strength	(none)	forelimb grip strength by trial [g] front_paws forelimb_strength 101561 trial1 trial2 trial3	KOMP	119	both	66-72wks	N=8	2021

JaxKOMP-LAP:134	JaxKOMP-LAP	grip strength	(none)	forelimb and hindlimb grip strength by trial [g] all_paws forehind_limb_strength 101564 trial1 trial2 trial3	KOMP	119	both	66-72wks	N=8	2021

JaxKOMP-LAP:138	JaxKOMP-LAP	grip strength	(none)	forelimb grip strength (mean of trials) [g] font_paws_mean forelimb_grip_mean 101571 average average normalized to bw	KOMP	119	both	66-72wks	N=8	2021

JaxKOMP-LAP:140	JaxKOMP-LAP	grip strength	(none)	forelimb and hindlimb grip strength (mean of trials) [g] all_paws_mean fore_and_hind_limb_grip_mean 101572 average average normalized to bw	KOMP	119	both	66-72wks	N=8	2021

Jaxpheno7:28	Jaxpheno7	observation (SHIRPA)	(none)	gait assessment within the arena (score 0-3) [score] gait 34928	inbred	6	m	10wks	N=8	2010

Jaxpheno7:30	Jaxpheno7	observation (SHIRPA)	(none)	body tone assessed by thumb and index finger compression while on horizontal wire-grid (score 0-2) [score] body_tone 34930	inbred	6	m	10wks	N=8	2010

Jaxpheno7:31	Jaxpheno7	observation (SHIRPA)	(none)	resistance to gentle finger-tip pressure of the hind paws during supine restraint (score 0-4) [score] limb_tone 34931	inbred	6	m	10wks	N=8	2010

Jaxpheno7:32	Jaxpheno7	observation (SHIRPA)	(none)	abdominal tone via palpation during supine restraint (score 0-2) [score] abdominal_tone 34932	inbred	6	m	10wks	N=8	2010

Jaxpheno7:59	Jaxpheno7	grip strength	(none)	grip strength, peak tension [g] grip 34959 trial1 trial2 trial3	inbred	6	m	10wks	N=8	2010

Jaxpheno7:62	Jaxpheno7	grip strength	(none)	grip strength mean peak tension over 3 trials [g] mean_grip 34962	inbred	6	m	10wks	N=8	2010

Jaxpheno7:63	Jaxpheno7	grip strength	(none)	grip strength maximum peak tension over 3 trials [g] max_grip 34963	inbred	6	m	10wks	N=8	2010

Jaxwest1:21	Jaxwest1	grip strength	(none)	grip strength mean peak tension over 5 trials [g] tension_mean 15121	inbred	7	both	9-12wks	N=8	2003

Jaxwest1:22	Jaxwest1	grip strength	(none)	grip strength maximum peak tension over 5 trials [g] tension_max 15122	inbred	7	both	9-12wks	N=8	2003

Karst1:6	Karst1	organ weights	(none)	muscle mass, as the sum of 2 Musculus longissimus (ml) + 2 Musculus quadriceps (mq) [g] msclemass 26006	QTL population		both	10wks	N=166	2011

Karst1:10	Karst1	organ weights	(none)	muscle mass, log-transformed [log(g)] logmsclemass 26010	QTL population		both	10wks	N=166	2011

Karst1:25	Karst1	metabolite quantification	(none)	glycogen content of the M. longissimus [mg/g] glyc 26025	QTL population		both	10wks	N=166	2011

Karst1:26	Karst1	metabolite quantification	(none)	glycogen content of the M. longissimus, log transformed [log(mg/g)] logglyc 26026	QTL population		both	10wks	N=166	2011

Karst1:27	Karst1	metabolite quantification	(none)	lactate content of the M. longissimus [mg/g] lac 26027	QTL population		both	10wks	N=166	2011

Karst1:28	Karst1	metabolite quantification	(none)	lactate content of the M. longissimus, log transformed [log(mg/g)] loglac 26028	QTL population		both	10wks	N=166	2011

Lake2:13	Lake2	observation (SHIRPA)	(none)	gait assessment within the arena (score 0-3) [score] gait 21713	B6.A consomic w/par	23	both	8wks	N=8	2005

Lake2:15	Lake2	observation (SHIRPA)	(none)	body tone assessed by thumb and index finger compression while on horizontal wire-grid (score 0-2) [score] body_tone 21715	B6.A consomic w/par	23	both	8wks	N=8	2005

Lake2:16	Lake2	observation (SHIRPA)	(none)	resistance to gentle finger-tip pressure of the hind paws during supine restraint (score 0-4) [score] limb_tone 21716	B6.A consomic w/par	23	both	8wks	N=8	2005

Lake2:17	Lake2	observation (SHIRPA)	(none)	abdominal tone via palpation during supine restraint (score 0-2) [score] abdominal_tone 21717	B6.A consomic w/par	23	both	8wks	N=8	2005

Lake3:13	Lake3	grip strength	(none)	grip strength mean peak tension over 3 trials [g] mean_grip 19013	B6.A consomic w/par	23	both	8-9wks	N=8	2005

Lake3:14	Lake3	grip strength	(none)	grip strength maximum peak tension over 3 trials [g] max_grip 19014	B6.A consomic w/par	23	both	8-9wks	N=8	2005

Lionikas1:11	Lionikas1	muscle weights	exercise	weight of tibialis anterior muscle [g] tibialis 48511 control exercise	inbred	6	m	11-14wks	N=15	2012

Lionikas1:12	Lionikas1	muscle weights	exercise	weight of extensor digitorum longus muscle [g] extensor 48512 control exercise	inbred	6	m	11-14wks	N=15	2012

Lionikas1:13	Lionikas1	muscle weights	exercise	weight of gastrocnemius muscle [g] gastrocnemius 48513 control exercise	inbred	6	m	11-14wks	N=15	2012

Lionikas1:14	Lionikas1	muscle weights	exercise	weight of quadriceps femoris muscle [g] quadriceps 48514 control exercise	inbred	6	m	11-14wks	N=15	2012

Lionikas1:15	Lionikas1	muscle weights	exercise	weight of soleus muscle [g] soleus 48515 control exercise	inbred	6	m	11-14wks	N=15	2012

Lionikas1:16	Lionikas1	microscopy	exercise	cross-sectional area of type I fibers of soleus muscle [µm²] soleus_area1 48516 control exercise	inbred	6	m	11-14wks	N=6	2012

Lionikas1:17	Lionikas1	microscopy	exercise	cross-sectional area of type IIa fibers of soleus muscle [µm²] soleus_area2A 48517 control exercise	inbred	6	m	11-14wks	N=6	2012

Lionikas1:18	Lionikas1	microscopy	exercise	total number of fibers of soleus muscle [n] soleus_fibers 48518 control exercise	inbred	6	m	11-14wks	N=6	2012

Lionikas1:19	Lionikas1	microscopy	exercise	number of type I fibers of soleus muscle [n] soleus_fibers1 48519 control exercise	inbred	6	m	11-14wks	N=6	2012

Lionikas1:20	Lionikas1	microscopy	exercise	number of type IIa fibers of soleus muscle [n] soleus_fibers2A 48520 control exercise	inbred	6	m	11-14wks	N=6	2012

Lionikas1:21	Lionikas1	microscopy	exercise	number of intermediate fibers of soleus muscle [n] soleus_intermediate 48521 control exercise	inbred	6	m	11-14wks	N=6	2012

Lionikas1:22	Lionikas1	protein activity assessment	exercise	citrate synthase activity of gastrocnemius muscle [U/g] citrate_synthase 48522 control exercise	inbred	6	m	11-14wks	N=8	2012

Lionikas1:23	Lionikas1	protein activity assessment	exercise	β-hydroxyacyl-CoA dehydrogenase activity of gastrocnemius muscle [U/g] CoA 48523 control exercise	inbred	6	m	11-14wks	N=8	2012

Neuner1:50	Neuner1	grip strength	(none)	mean grip strength across 3 trials [g] grip_strength 65950 6 mo 14 mo	F1 AD-BXD	55	both	23-57wks	N=6	2019

Project1133:116	Project1133	grip strength	various diets 3	all-paws force - 3 trial average [Z-score] GS_APAW 116328 diet: AL 1D 2D 20 40	DO population		f	44 wks	N=130	2022

Project1133:121	Project1133	grip strength	various diets 3	forepaws force - 3 trial average [Z-score] GS_FORE 116333 AL 1D 2D 20 40	DO population		f	44 wks	N=130	2022

Project1170:13	Project1170	grip strength	fluoxetine	grip strength forepaws, trial 1 [g] forepaw_T1 121669 group: control fluoxetine	inbred	6	m	8-9wks	N=10	2023

Project1170:15	Project1170	grip strength	fluoxetine	grip strength forepaws, trial 2 [g] forepaw_T2 121671 group: control fluoxetine	inbred	6	m	8-9wks	N=10	2023

Project1170:17	Project1170	grip strength	fluoxetine	grip strength forepaws, trial 3 [g] forepaw_T3 121673 group: control fluoxetine	inbred	6	m	8-9wks	N=10	2023

Project1170:19	Project1170	grip strength	fluoxetine	grip strength forepaws, average of all trials [g] forepaw_avg 121675 group: control fluoxetine	inbred	6	m	8-9wks	N=10	2023

Project1170:21	Project1170	grip strength	fluoxetine	grip strength forepaws, average of all trials adjusted for body weight [g] forepaw_avg_adj 121677 group: control fluoxetine	inbred	6	m	8-9wks	N=10	2023

Project1170:23	Project1170	grip strength	fluoxetine	grip strength all paws, trial 1 [g] all_paw_T1 121679 group: control fluoxetine	inbred	6	m	8-9wks	N=10	2023

Project1170:25	Project1170	grip strength	fluoxetine	grip strength all paws, trial 2 [g] all_paw_T2 121681 group: control fluoxetine	inbred	6	m	8-9wks	N=10	2023

Project1170:27	Project1170	grip strength	fluoxetine	grip strength all paws, trial 3 [g] all_paw_T3 121683 group: control fluoxetine	inbred	6	m	8-9wks	N=10	2023

Project1170:29	Project1170	grip strength	fluoxetine	grip strength all paws, average of all trials [g] all_paw_avg 121685 group: control fluoxetine	inbred	6	m	8-9wks	N=10	2023

Project1170:31	Project1170	grip strength	fluoxetine	grip strength all paws, average of all trials adjusted for body weight [g] all_paw_avg_adj 121687 group: control fluoxetine	inbred	6	m	8-9wks	N=10	2023

Schoonjans1:230	Schoonjans1	organ weights	high-fat diet	gastrocnemius muscle weight [g] gastroc_wt 112865 CD HFD	BXD w/par	35	m	29wks	N=5	2021

Schoonjans1:232	Schoonjans1	organ weights	high-fat diet	soleus muscle weight [g] soleus_wt 112867 CD HFD	BXD w/par	35	m	29wks	N=5	2021

Seburn2:1	Seburn2	grip strength	(none)	grip strength, peak tension over 3 trials [g] grip_strength 24801 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2008

An error occurred on this page.These results could be incomplete or invalid. Staff have been notified.

Filter Table Results

An error occurred on this page.
These results could be incomplete or invalid. Staff have been notified.